When the medications were developed, only people with diabetes could get a prescription for injectable GLP-1 medications. This specific class of medications help the body produce more insulin, and therefore, control blood sugar levels. However, since 2014 GLP-1s have been approved as an obesity treatment, with more and more evidence that GLP-1 medications are beneficial for more than just diabetes and weight loss. Now, the challenge for some people is just figuring out: Who is eligible for Ozempic?

“Identifying the right candidates is crucial to ensure the safe and effective use of GLP-1s,” Dr. Supatra Tovar, RD, tells Woman’s World. “These medications may come with side effects such as gastrointestinal disturbances, pancreatitis, and thyroid tumors, particularly in certain high-risk populations. By targeting individuals who stand to benefit the most, healthcare providers can maximize the benefits while minimizing potential risks​.”